Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use - Supplemental Tables.docx

  

Supplementary Table 1: Patient demographic characteristics and prescriber specialty

  

Supplementary Table 2: Baseline comorbidities

  

Supplementary Table 3: Baseline medication use

  

Supplementary Table 4: Baseline healthcare utilization, and costs

  

Supplementary Table 5: Number of index medication fills before biologic initiation during the 1-year follow-up period

  

Supplementary Table 6: First biologic medication used during the 1-year follow-up period among apremilast patients who initiated biologic

  

Supplementary Table 7: First biologic medication used during the 1-year follow-up period among methotrexate patients who initiated biologic

  

Supplementary Table 8: Biologic initiation adjusted results